Advisors Asset Management Inc. Reduces Stake in GE HealthCare Technologies Inc. $GEHC

Advisors Asset Management Inc. cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 94,618 shares of the company’s stock after selling 11,435 shares during the period. Advisors Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $7,008,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of GEHC. Avantax Advisory Services Inc. lifted its stake in shares of GE HealthCare Technologies by 16.0% in the 1st quarter. Avantax Advisory Services Inc. now owns 13,481 shares of the company’s stock valued at $1,088,000 after purchasing an additional 1,860 shares during the period. Cetera Investment Advisers raised its stake in GE HealthCare Technologies by 0.8% during the 1st quarter. Cetera Investment Advisers now owns 80,168 shares of the company’s stock valued at $6,470,000 after buying an additional 624 shares during the last quarter. Assetmark Inc. increased its position in shares of GE HealthCare Technologies by 24.9% during the 1st quarter. Assetmark Inc. now owns 6,239 shares of the company’s stock valued at $504,000 after purchasing an additional 1,243 shares during the last quarter. HB Wealth Management LLC lifted its stake in shares of GE HealthCare Technologies by 51.6% in the 1st quarter. HB Wealth Management LLC now owns 12,682 shares of the company’s stock worth $1,024,000 after purchasing an additional 4,316 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of GE HealthCare Technologies by 3.8% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 173,361 shares of the company’s stock valued at $13,992,000 after acquiring an additional 6,271 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on GEHC shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, November 17th. Wells Fargo & Company cut their target price on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price target for the company from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Stifel Nicolaus set a $90.00 target price on GE HealthCare Technologies in a report on Friday. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $86.45.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $79.96 on Wednesday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The business has a 50-day moving average price of $74.76 and a 200 day moving average price of $74.03. The firm has a market cap of $36.42 billion, a PE ratio of 16.52, a P/E/G ratio of 3.27 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter last year, the firm posted $1.14 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s payout ratio is 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.